Company Directory - Spyre Therapeutics, Inc.
Company Details - Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc.
WebsiteA biopharmaceutical company focused on developing therapies for serious diseases.
CCI Score
CCI Score: Spyre Therapeutics, Inc.
1.00
Latest Event
Spyre Therapeutics Adopts Comprehensive Human Rights Policy
Spyre Therapeutics, Inc. published a detailed Human Rights Policy on January 9, 2025, affirming its commitment to ethical labor practices, fair treatment, equal opportunity, and compliance with international human rights standards. The policy outlines measures to ensure safe and healthy workplaces, prohibit forced and child labor, and support diversity and inclusion among employees and supply chain partners.
Take Action
So what can you do? Support by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
OBJECTOR
Spyre Therapeutics, Inc. is currently rated as an Objector.
Latest Events
- JAN092025
Spyre Therapeutics, Inc. published a detailed Human Rights Policy on January 9, 2025, affirming its commitment to ethical labor practices, fair treatment, equal opportunity, and compliance with international human rights standards. The policy outlines measures to ensure safe and healthy workplaces, prohibit forced and child labor, and support diversity and inclusion among employees and supply chain partners.
+80
Labor Relations and Human Rights Practices
April 8
The newly published policy demonstrates a strong commitment to labor rights and human dignity. By establishing clear standards that protect workers, ensure fair compensation, and promote safe working conditions, Spyre Therapeutics is taking a proactive, anti-authoritarian stance that supports marginalized communities and adheres to internationally recognized human rights principles.
PDF Spyre Therapeutics, Inc. Human Rights Policy I. Introduction
- DEC312023
Data from OpenSecrets shows that Spyre Therapeutics spent $30,000 on lobbying activities in 2023, indicating corporate political influence that may contribute to undermining democratic accountability and reinforcing entrenched power structures.
-40
Political Contributions and Lobbying Efforts
April 8
Spyre Therapeutics' reported expenditure of $30,000 on lobbying in 2023 highlights a concerted effort to influence political outcomes. In the current climate of rising authoritarianism, such corporate political spending is viewed as enabling influence by entrenched power structures, potentially undermining democratic processes and workers' rights.
- JAN012023
Spyre Therapeutics spent $30,000 on lobbying activities in 2023, as detailed in OpenSecrets reports. This expenditure reflects the company's engagement in corporate political lobbying, which may exert influence on policy-making processes.
-50
Political Contributions and Lobbying Efforts
April 8
The report of Spyre Therapeutics spending $30,000 on lobbying in 2023 raises concerns regarding corporate influence in political processes. From an anti-fascist perspective, such lobbying practices can be seen as efforts to shape public policy in favor of corporate interests, potentially undermining democratic accountability and progressive reforms.
Alternatives
Kenilworth, United States
2.89
New Haven, USA
-38.83
Corporation
2.31
Corporation
1.66
Copenhagen, Denmark
2.36
Corporation
3.48
Corporation
0.00
Corporation
-43.74
Belgium (Ghent), Belgium
79.03
Raleigh, USA
56.52
Industries
- 325412
- Pharmaceutical Preparation Manufacturing
- 541712
- Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)
- 541711
- Research and Development in Biotechnology